Literature DB >> 12442664

Dopamine receptors in Parkinson's disease: imaging studies.

A Jon Stoessl1, Raúl de la Fuente-Fernández.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12442664

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  4 in total

1.  Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study.

Authors:  Antonio P Strafella; Ji Hyun Ko; Joshua Grant; Maria Fraraccio; Oury Monchi
Journal:  Eur J Neurosci       Date:  2005-12       Impact factor: 3.386

2.  Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.

Authors:  Mei-Ping Kung; Catherine Hou; Rajesh Goswami; Datta E Ponde; Michael R Kilbourn; Hank F Kung
Journal:  Nucl Med Biol       Date:  2007-04       Impact factor: 2.408

3.  Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([(18)F]AV-133).

Authors:  Yajing Liu; Feng Yue; Rongping Tang; Guoxian Tao; Xiaomei Pan; Lin Zhu; Hank F Kung; Piu Chan
Journal:  Neurosci Bull       Date:  2013-09-05       Impact factor: 5.203

4.  Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.

Authors:  Kenneth Blum; Amanda L C Chen; Marlene Oscar-Berman; Thomas J H Chen; Joel Lubar; Nancy White; Judith Lubar; Abdalla Bowirrat; Eric Braverman; John Schoolfield; Roger L Waite; Bernard W Downs; Margaret Madigan; David E Comings; Caroline Davis; Mallory M Kerner; Jennifer Knopf; Tomas Palomo; John J Giordano; Siobhan A Morse; Frank Fornari; Debmalya Barh; John Femino; John A Bailey
Journal:  Int J Environ Res Public Health       Date:  2011-11-29       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.